Exclusive: J&J out of race for Pfizer's $20 billion consumer unit as deadline looms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
'Steady Bullish' Options Activity in Pfizer (PFE) Ahead of Q4 Earnings Announcement on Jan. 30th -Susquehanna
January 26, 2018 2:39 PM ESTSusquehanna options strategist Alison Edwards notes "steady bullish" options activity in Pfizer (NYSE: PFE) ahead of fourth quarter earnings on Jan. 30th, as investors purchased ~20,000 Feb 38 Calls and 10,000 Feb 38.5 Calls.
... More